glp-1 obesity drug news october 9 2025 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom Looming GLP-1 drug patent expirations
Description
doi: 10.1016/j.lfs.2020.117996 4 ScheltensPDe StrooperBKivipeltoMHolstegeHChtelatGTeunissenCEet al
"Roche Carmot acquisition positions company in GLP-1 space." [43] Morningstar
A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes
Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
*Disclaimer: Mounjaro and Zepbound are both registered trademarks of Eli Lilly
From there, well recommend a treatment plan tailored to your needs, including the most appropriate GLP-1 option and dosage to help you achieve your goals safely and effectively
